1. Andreoni M, Giacometti A, Maida I, et al. HIV-HCV co- infection: epidemiology, pathogenesis and therapeutic implications. Eur Rev Med Pharmacol Sci 2012;16:1473-1483.
2. Klein MB, Rockstroh JK, Wittkop L. Effect of coinfection with hepatitis C virus on survival of individuals with HIV-1 infection. Curr Opin HIV AIDS 2016;11:521-526.
3. Verucchi G, Calza L, Manfredi R, et al. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 2004;32:33-46.
4. Bosh KA, Coyle JR, Hansen V, et al. HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities. Epidemiol Infect 2018;146:920-930.
5. Danta M, Rodger AJ. Transmission of HCV in HIV-positive populations. Curr Opin HIV AIDS 2011;6:451-458.
6. Urbanus AT, van de Laar TJ, Stolte IG, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009;23:F1-F7. doi: 10.1097/QAD.0b013e32832e5631.
7. Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis 2016;20:607-628.
8. Abara WE, Qaseem A, Schillie S, et al. Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med 2017;167:794-804.
9. Thornton AC, Jose S, Bhagani S, et al. Hepatitis B, hepatitis C, and mortality among HIV-positive individuals. AIDS 2017;31:2525-2532.
10. Prussing C, Chan C, Pinchoff J, et al. HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics. Epidemiol Infect 2015;143:1408-1416.
11. Speers S, Klevens RM, Vonderwahl C, et al. Electronic matching of HIV/AIDS and hepatitis C surveillance registries in three states. Public Health Rep 2011;126:344-348.
12. Chun HM, Fieberg AM, Hullsiek KH, et al. The epidemiology of hepatitis B virus infection in a U.S. cohort of HIV-infected individuals during the last 20 years. Clin Infect Dis 2010;50:426-436.
13. Butt ZA, Wilkins MJ, Hamilton E, et al. Hepatitis B and C co-infection in HIV/AIDS population in the state of Michigan. Epidemiol Infect 2013;141:2604-2611.
15. Fellegi IP, Sunter AB. A theory for record linkage. J Am Stat Assoc 1969;64:1183.
16. Centers for Disease Control and Prevention, National Notifiable Diseases Surveillance System. Surveillance case definitions for current and historical conditions. https://wwwn.cdc.gov/nndss/conditions
. Published August 2, 2017. Accessed November 3, 2017.
17. Ham DC, Huang Y, Gvetadze R, et al. Health care use and HIV testing of males aged 15-39 years in physicians’ offices-United States, 2009-2012. MMWR Morb Mortal Wkly Rep 2016;65:619-622.
18. Wejnert C, Hess KL, Hall HI, et al. Vital signs: trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs-United States. MMWR Morb Mortal Wkly Rep 2016;65:1336-1342.
19. Singh S, Hu X, Wheeler W, et al. HIV diagnoses among men who have sex with men and women-United States and 6 dependent areas, 2008-2011. Am J Public Health 2014;104:1700-1706.
20. Reif S, Safley D, McAllaster C, et al. State of HIV in the US Deep South. J Community Health 2017;42:844-853.
21. Prejean J, Tang T, Hall HI. HIV diagnoses and prevalence in the southern region of the United States, 2007-2010. J Community Health 2013;38:414-426.
22. Tedaldi EM, Hullsiek KH, Malvestutto CD, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 2003;36:1313-1317.
23. Bradshaw D, Matthews G, Danta M. Sexually transmitted hepatitis C infection: the new epidemic in MSM? Curr Opin Infect Dis 2013;26:66-72.
24. Hagan H, Jordan AE, Neurer J, et al. Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men. AIDS 2015;29:2335-2345.
25. Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection-an update. Microb Cell 2016;3:420-437.
26. Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis 2002;35:1382-1387.
27. Platt L, Minozzi S, Reed J, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database System Rev 2017;9:CD012021.
28. Canary L, Hariri S, Campbell C, et al. Geographic disparities in access to syringe services programs among young persons with hepatitis C virus infection in the United States. Clin Infect Dis 2017;65:514-517.
29. Sharp A, Jones A, Sherwood J, et al. Impact of Medicaid expansion on access to opioid analgesic medications and medication-assisted treatment. Am J Public Health 2018;108:642-648.
30. Onofrey S, Aneja J, Haney GA, et al. Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review. Ann Intern Med 2015;163:254-261.
31. Zhou Y-H, Yao Z-H, Liu F-L, et al. High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan Province, China. PLoS One 2012;7:e42937.